Prednisolon Alternova 5 mg Norwegia - norweski - Statens legemiddelverk

prednisolon alternova 5 mg

alternova - prednisolon - tablett - 5 mg

Prednisolon Alternova 20 mg Norwegia - norweski - Statens legemiddelverk

prednisolon alternova 20 mg

alternova - prednisolon - tablett - 20 mg

Dynastat Unia Europejska - norweski - EMA (European Medicines Agency)

dynastat

pfizer europe ma eeig - parecoxibnatrium - smerte, postoperativ - coxibs, antiinflammatory and antirheumatic products - for kortsiktig behandling av postoperativ smerte hos voksne.

Eucreas Unia Europejska - norweski - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Unia Europejska - norweski - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Zomarist Unia Europejska - norweski - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Delmosart 18 mg Norwegia - norweski - Statens legemiddelverk

delmosart 18 mg

teva b.v. - metylfenidathydroklorid - depottablett - 18 mg

Delmosart 27 mg Norwegia - norweski - Statens legemiddelverk

delmosart 27 mg

teva b.v. - metylfenidathydroklorid - depottablett - 27 mg

Delmosart 36 mg Norwegia - norweski - Statens legemiddelverk

delmosart 36 mg

teva b.v. - metylfenidathydroklorid - depottablett - 36 mg

Delmosart 54 mg Norwegia - norweski - Statens legemiddelverk

delmosart 54 mg

teva b.v. - metylfenidathydroklorid - depottablett - 54 mg